Rg3 can inhibit the growth of A549/DDP cells and reduce their resistance to cisplatin by preventing the expression of NF‐κB from decreasing the expression of PD‐L1 induced by chemical resistance and restoring the cytotoxicity of T cells toward cancer cells.182. This evidence concerns the gene NFKB1 and cancer.